The involvement of muscles in the pathogenesis of transmissible spongiform encephalopathies (TSEs) is irregular and unpredictable. We show that the TSE-specific protein (PrP TSE ) is present in muscles of mice fed with a mouse-adapted strain of bovine spongiform encephalopathy as early as 100 days post-infection, corresponding to about one-third of the incubation period. The proportion of mice with PrP TSE -positive muscles and the number of muscles involved increased as infection progressed, but never attained more than a limited distribution, even at the clinical stage of disease. The appearance of PrP TSE in muscles during the preclinical stage of disease was probably due to the haematogenous/lymphatic spread of infectivity from the gastrointestinal tract to lymphatic tissues associated with muscles, whereas in symptomatic animals, the presence of PrP TSE in the nervous system, in neuromuscular junctions and in muscle fibres suggests a centrifugal spread from the central nervous system, as already observed in other TSE models.
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Transmissible spongiform encephalopathies (TSEs) are neurodegenerative disorders caused by an atypical infectious agent called 'prion' (hence the definition of 'prion disorders'), mainly composed of a pathologically folded host protein called PrP TSE . Natural TSEs comprise kuru, Creutzfeldt-Jakob disease (CJD), Gerstmann-Sträussler-Scheinker syndrome and fatal familial insomnia in humans, scrapie in sheep and goats, chronic wasting disease in cervids, transmissible mink encephalopathy (TME) and bovine spongiform encephalopathy (BSE) (Johnson, 2005; Manson et al., 2006) . Other species, however, are also susceptible to TSEs, as shown by accidental (e.g. feline spongiform encephalopathy) or experimental (e.g. rodents, non-human primates) transmissions. In the central nervous system (CNS), massive replication of infectivity is accompanied by spongiosis, gliosis, neuronal loss and PrP TSE accumulation. Peripheral tissues, like those of the lymphoreticular system (e.g. spleen), viscera (e.g. liver), body fluids (e.g. blood) and muscle, contain lower levels of PrP TSE and infectivity (WHO, 2006) .
In recent years, the search for TSE infectivity in muscles has become intensive, due to the importance of this tissue in the human diet and as a potential source of crosscontamination during invasive medical and surgical procedures, with the attendant risk of iatrogenic transmission of disease. The presence and distribution of infectivity or PrP TSE accumulation in muscles of 'natural' TSE infections differ in different host-strain combinations (Andréoletti et al., 2004; Angers et al., 2006; Beekes & McBride, 2007; Bosque et al., 2002; Casalone et al., 2005; Glatzel et al., 2003; Herzog et al., 2005; Peden et al., 2006; Thomzig et al., 2004 Thomzig et al., , 2006 . This heterogeneity has also been observed in experimental models of TSEs. In hamsters fed with 263K scrapie, PrP TSE and infectivity accumulate in muscles much later than in the CNS, suggesting a centrifugal neural spread of infection from the CNS into muscles (Thomzig et al., 2004 neuromuscular junctions and muscle spindles in scrapieor TME-infected hamsters (Mulcahy et al., 2004; Thomzig et al., 2004) and in scrapie-infected sheep (Andréoletti et al., 2004) . In mice experimentally infected intracerebrally with BSE, the presence of PrP TSE in muscles is more restricted than in hamsters (Thomzig et al., 2003 (Thomzig et al., , 2006 , but it is similar to that found in CJD patients (Glatzel et al., 2003; Peden et al., 2006) and in sheep with scrapie (Andréoletti et al., 2004) . Because the oral route of infection can be important in the occurrence of some 'natural' TSEs, as well as variant CJD (Safar et al., 2008; Sigurdson & Aguzzi, 2007; Ward et al., 2006) , we studied the chronological deposition of PrP TSE in muscles of mice fed with a mouseadapted BSE strain.
To prepare the infectious BSE inoculum, brains from terminally ill C57BL/6 mice infected with the BSE isolate 6PB1 (Maignien et al., 1999 ; kindly provided by Dr JeanPhilippe Deslys, CEA, Fontenay-aux-Roses, France) were homogenized in 9 vols PBS. Clarified inoculum (100 ml) was then absorbed by food pellets and fed immediately to individually caged adult female C57BL/6 mice (n526) previously subjected to 2 days starvation. After complete ingestion of BSE-infected pellets, the animals were housed (eight per cage) and observed daily for clinical signs of BSE. Groups of five animals were sedated and sacrificed by CO 2 asphyxia during the preclinical stage of the disease at 100, 200 and 300 days post-infection (p.i.). One mouse died of intercurrent disease after 290 days. The remaining animals were sacrificed at clinical onset. Control animals (n59) were fed pellets soaked with normal mouse-brain homogenate and were sacrificed following the schedule described for BSE-infected mice. All animals were autopsied and brain, spleen and a set of nine different muscles were sampled and either fixed in formalin for histological examination or frozen at 270 u C for PrP27-30 (the protease-resistant form of PrP TSE ) purification, biochemical and paraffin-embedded tissue (PET)-blot analyses (Thomzig et al., 2003 (Thomzig et al., , 2004 (Thomzig et al., , 2006 . All mice allowed to survive became symptomatic, with a mean±SD incubation period of 368.3±13.7 days (n510), confirming the efficiency of the oral route of infection in mouse BSE. As shown in Table 1 and Fig. 1 , the earliest PrP TSE -positive immunoblots (one Musculus triceps brachii caput laterale and one M. trapezius) occurred in two different mice sacrificed at 100 days p.i. The proportion of PrP TSE -positive mice increased as the incubation period progressed and, at 300 days p.i., multiple muscle involvement began to occur. Heart and tongue samples, as well as muscles from mock-infected animals, were consistently PrP TSE -negative.
Among the entire group of infected animals, six of the nine sampled muscles were affected, with M. psoas major being involved most often, in both the preclinical and clinical stages. Immunoblot signals of PrP27-30 from 20-50 mg muscle were comparable to those of positive controls containing 10 mg equivalents of mouse BSE brain and to those of muscle from uninfected mice spiked with 50 mg equivalents of brain, suggesting that the level of PrP TSE in muscles is about three orders of magnitude lower than that in the brain. Analyses of muscles from mock-infected mice and some BSE-infected mice showed thin bands at about 30 kDa (e.g. Fig. 1a , lanes M2, M5-M9; Fig. 1e , lanes M1-M3), sometimes appearing as a doublet, also visible after omission of the primary anti-PrP antibody, that were clearly distinguishable from PrP27-30 triple bands and were therefore considered unrelated to TSE infection. Analysis of brains from infected mice showed PrP TSE in two of five asymptomatic mice sacrificed at 300 days p.i. (during the preclinical period) and in all symptomatic animals. The electrophoretic pattern of PrP27-30 from muscles and brain was indistinguishable from the typical BSE signature observed in intracerebrally infected mice.
Immunohistochemical studies in preclinical animals showed granular PrP TSE deposition in the brainstem and pontine reticular nuclei (Fig. 2a) . PET-blots of M. triceps brachii and M. psoas major were performed in some mice (Table 1 ) and revealed PrP TSE positivity only in the lymphatic tissue associated with muscle of preclinical animals. In brains from clinically affected animals, granular deposition was associated with PrP TSE plaques in the thalamus, mesencephalon, cerebellar cortex, pons and brainstem, together with spongiosis in the brainstem and cerebellum (Fig. 2b-d) . In these animals, PET-blots of M. triceps brachii and M. psoas major revealed PrP TSE in the muscle, single fibres of small nerves and neuromuscular junctions.
To evaluate the involvement of the lymphoreticular system, spleens were analysed by immunoblot and found to be PrP TSE -positive from 100 days p.i. onward (Table 1 ). All but one animal with PrP TSE -positive muscles had moderate to high PrP TSE load in the spleen (Fig. 1h) .
The novelty of these data is that, in our rodent model for BSE in cattle, i.e. mice infected orally with a mouseadapted BSE strain, there is an unexpected early preclinical deposition of PrP TSE in muscles, probably associated with the lymphatic tissues, which occurs as early as during the first one-third of the incubation period. This result is similar to what has been found in sheep infected orally with scrapie, where muscle PrP TSE was detected during the first one-quarter of the incubation period (Andréoletti et al., 2004) . Interestingly, this phenomenon does not occur in all TSE models; for example, in hamsters fed with 263K scrapie, muscles only became PrP TSE -positive near clinical onset (Thomzig et al., 2004) .
The early involvement of spleen and other lymphatic tissues found in this study is consistent with the observations reported by Maignien et al. (1999) in mice infected with the same BSE strain and by the same route. Interestingly, they also observed that in the later stages of the incubation period, PrP TSE appeared simultaneously in the thoracic spinal cord and brain, suggesting that after oral infection, the BSE agent spreads by blood or lymph to Non-infected 100-368 days p.i. § 0/9 0/9 0/9 0/9 0/9 0/9 0/9 0/9 0/9 0/9 0/9 *Nerves and lymphatic tissues were not present in mouse 5; lymphatic tissues were not present in mice 7, 13, 25 or 26. PrP TSE positivity was always associated with the lymphatic tissues, except in mouse 25 (positive in neuromuscular junction) and mouse 26 (positive in muscle, single fibres and small nerves). DLymphatic tissues were not present in mice 1, 6, 13 or 26. PrP TSE positivity was always associated with lymphatic tissues, except in mouse 26
(positive in neuromuscular junction). dMean±SD. §Two mice per time point were sacrificed at 100, 200 and 300 days p.i. Three mice were sacrificed at 368 days p.i.
lymphatic tissues associated with muscles, and only at a later stage during the incubation period enters the CNS and is then projected into muscles via nerve fibres.
The late centrifugal spread of PrP TSE from the CNS to muscle in orally BSE-infected mice is also consistent with observations in other experimental models (Thomzig et al., 2004; Herzog et al., 2005) or in scrapie-infected sheep (Andréoletti et al., 2004) , where the CNS plays a primary role in the dissemination of infectivity to muscles (Beekes & McBride, 2007) .
In the light of these new data, there would seem to be a very low probability that BSE-infected cows harbour infectivity in muscle destined for human consumption, in view of the minimal involvement of the lymphoreticular system in cattle and the continued absence of evidence for infectivity in bovine muscles (Buschmann & Groschup, 2005; Espinosa et al., 2007; WHO, 2006) . It is nevertheless possible that limited muscle sampling and methodological insensitivity could fail to detect the irregular "5 g equivalents of proteinase K-digested brain homogenate from BSE-affected mice ('digested mouse BSE brain'); 2, uninfected muscle spiked with 5¾10
"5 g equivalents of digested mouse BSE brain before extraction. F. Cardone and others distribution of low levels of PrP TSE in muscle. Moreover, the absence of PrP TSE does not necessarily imply absence of infectivity (Barron et al., 2007; Berardi et al., 2006; Lasmézas et al., 1997) . A more thorough examination of entire muscle groups using the ultrasensitive proteinmisfolding cyclic-amplification technique (Soto et al., 2005) might yield a positive result, but would need to be verified by infectivity bioassay before inferring a risk of disease transmission. 
